Consensus Core Laboratories Inc.

Stocks

CLB

US21867A1051

Business Support Services

Market Closed - NYSE 01:30:02 05/09/2026 am IST			5-day change	1st Jan Change
12.54 ^USD	+0.08%		+1.46%	-21.77%

26/08	Core Laboratories Inc. Announces Resignation of Kwaku Temeng as Director, Chairman of the Nominating Committee and as A Member of the Compensation Committee, Effective October 1, 2026	CI
30/07	Core Laboratories Inc., Q2 2026 Earnings Call, Jul 30, 2026

Evolution of the Average Target: Core Laboratories Inc.

Evolution of the Target Price: Core Laboratories Inc.

Changes in Analyst Recommendations: Core Laboratories Inc.

3f541ebc5459e7b5066.8htnr19yYy1Kt70S7Wj7t9RrdqpzzQIVHmRhmjV8sqE.tE4yzgA2W0cPxMVQmx6B7p0SLMNDuF1kWScNyEM52ZOFdj3lNCo7GT3d0g~228cc64dd91c568b0127575782026569

Analysts' recommendations: Core Laboratories Inc.

15/07	BofA Securities Adjusts Core Laboratories Price Target to $11 From $12	MT
12/25/12	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $16 From $15	MT
06/25/06	Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating	MT
25/24/25	The Zephirin Group Upgrades Core Laboratories to Buy from Hold; Adjusts Price Target to $22 from $18	MT
25/24/25	Zephirin Group Upgrades Core Laboratories to Buy Medium Risk From Hold Medium Risk, Raises Price Target to $22 From $18	MT
15/24/15	Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating	MT
29/24/29	Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating	MT
18/23/18	Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating	MT
31/23/31	Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating	MT
30/23/30	Citigroup Downgrades Core Laboratories to Sell From Neutral, Trims Price Target to $21 From $22	MT
01/23/01	Morningstar Upgrades Core Laboratories to Buy From Hold, $29 Price Target	MT
01/23/01	Piper Sandler Adjusts Core Laboratories' Price Target to $19 From $18, Keeps Neutral Rating	MT
28/23/28	Stifel Adjusts Core Laboratories' Price Target to $25 From $24, Keeps Hold Rating	MT
18/23/18	BofA Downgrades Core Laboratories to Underperform From Neutral, Price Target is $21.50	MT
07/23/07	Citigroup Adjusts Price Target on Core Laboratories N.V to $26 From $21, Maintains Neutral Rating	MT
09/23/09	BofA Securities Upgrades Core Laboratories to Neutral From Underperform	MT
07/22/07	Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $17 From $24	MT
26/22/26	Morgan Stanley Downgrades Core Laboratories to Underweight From Equal Weight, Keeps $20 Price Target	MT
02/22/02	Cowen Lowers Core Laboratories Price Target to $17 From $22, Maintains Market Perform Rating	MT
01/22/01	Morgan Stanley Lowers Core Laboratories' Price Target to $20 From $22, Maintains Equalweight Rating	MT
15/22/15	BofA Securities Adjusts Core Laboratories Price Target to $17 From $25, Maintains Underperform Rating	MT
13/22/13	Morgan Stanley Adjusts Core Laboratories' Price Target to $22 from $32, Keeps Equalweight Rating	MT
13/22/13	Morgan Stanley Adjusts Core Laboratories N.V 's Price Target to $22 From $32, Keeps Equalweight Rating	MT
02/22/02	Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating	MT
18/22/18	Piper Sandler Downgrades Core Laboratories to Underweight From Neutral	MT

More recommendations

Testing Laboratories

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
CORE LABORATORIES INC.	-			+21.04%
SGS SA				+10.61%
CENTRE TESTING INTERNATIONAL GROUP CO. LTD.				+31.96%
CHINA AUTOMOTIVE ENGINEERING RESEARCH INSTITUTE CO., LTD.		-	-	+49.04%
TIC SOLUTIONS, INC.				+30.71%
GRG METROLOGY & TEST GROUP CO., LTD.				+41.99%
EMTEK (SHENZHEN) CO., LTD.		-	-	-
Average				+30.89%
Weighted average by Cap.				+18.50%